EMA shortages Shortage ongoing Medicine shortages
Mycobutin (rifabutin) — supply shortage (shortage ongoing)
Published by European Medicines Agency:
Summary
Supply shortage
Medicine
Mycobutin (rifabutin)
- Category
- Medicine shortages
- Product type
- Human medicine
- Therapeutic area: Tuberculosis;Acquired Immunodeficiency Syndrome
- Pharmaceutical forms affected: Capsule
- Strengths affected: 150 mg
- Expected resolution: Expected to resolve by November 2026
Measures and alternatives
- Availability of alternatives: Yes, in some Member States
Source: EMA — medicine shortages — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗